1,3-benzodioxol-5-ylmethanamine,hydrochloride
CAS2620-49-7
1,3-benzodioxol-5-ylmethanamine,hydrochloride (CAS 2620-49-7, C8H10ClNO2) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 2620-49-7
- Formula
- C8H10ClNO2
- Mol. weight
- 213.62 g/mol
Chemical Specifications
Identifiers
| CAS number | 2620-49-7 |
|---|---|
| Product name | 1,3-benzodioxol-5-ylmethanamine,hydrochloride |
| Synonyms | 5-(azidomethyl)benzo[d][1,3]dioxole hydrochloride |
| Molecular formula | C8H10ClNO2 |
| Molecular weight | 213.62 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 1,3-benzodioxol-5-ylmethanamine,hydrochloride?
The CAS Registry Number of 1,3-benzodioxol-5-ylmethanamine,hydrochloride is 2620-49-7. 1,3-benzodioxol-5-ylmethanamine,hydrochloride is also known as 5-(azidomethyl)benzo[d][1,3]dioxole hydrochloride.
What is the molecular formula and molecular weight of 1,3-benzodioxol-5-ylmethanamine,hydrochloride?
The molecular formula of 1,3-benzodioxol-5-ylmethanamine,hydrochloride is C8H10ClNO2, and its molecular weight is 213.62 g/mol.
How can I request a quotation for 1,3-benzodioxol-5-ylmethanamine,hydrochloride?
Send an inquiry for 1,3-benzodioxol-5-ylmethanamine,hydrochloride (CAS 2620-49-7) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 1,3-benzodioxol-5-ylmethanamine,hydrochloride
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.